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Increased Presence of Monounsaturated Fatty
Acids in the Stratum Corneum of Human Skin
Equivalents
Varsha S. Thakoersing1,5, Jeroen van Smeden1,5, Aat A. Mulder1, Rob J. Vreeken2,3, Abdoelwaheb El Ghalbzouri4
and Joke A. Bouwstra1
Previous results showed that our in-house human skin equivalents (HSEs) differ in their stratum corneum (SC)
lipid organization compared with human SC. To elucidate the cause of the altered SC lipid organization in the
HSEs, a recently developed liquid chromatography/mass spectrometry method was used to study the free fatty
acid (FFA) and ceramide composition in detail. In addition, the SC lipid composition of the HSEs and human
skin was examined quantitatively with high-performance thin-layer chromatography. Our results reveal that all
our HSEs have an increased presence of monounsaturated FFAs compared with human SC. Moreover, the HSEs
display the presence of ceramide species with a monounsaturated acyl chain, which are not detected in human
SC. All HSEs also exhibit an altered expression of stearoyl-CoA desaturase, the enzyme that converts saturated
FFAs to monounsaturated FFAs. Furthermore, the HSEs show the presence of 12 ceramide subclasses, similar to
native human SC. However, the HSEs have increased levels of ceramides EOS and EOH and ceramide species
with short total carbon chains and a reduced FFA level compared with human SC. The presence of unsaturated
lipid chains in HSE offers new opportunities to mimic the lipid properties of human SC more closely.
Journal of Investigative Dermatology (2013) 133, 59–67; doi:10.1038/jid.2012.262; published online 16 August 2012
INTRODUCTION
Human skin equivalents (HSEs) provide a valuable tool to
predict the permeation of substances through the skin (Asbill
et al., 2000; Schmook et al., 2001; Zghoul et al., 2001;
Suhonen et al., 2003; Netzlaff et al., 2007; Schafer-Korting
et al., 2008; Batheja et al., 2009; Ackermann et al., 2010)
or to determine whether compounds are toxins, irritants, or
sensitizers for the skin (Netzlaff et al., 2005; El Ghalbzouri
et al., 2008; Alepee et al., 2009; Gibbs, 2009). However,
to obtain a reliable in vitro–in vivo correlation, it is a
prerequisite that HSEs have a comparable skin barrier
function as native human skin. The main barrier for
compound penetration is located in the lipid matrix of the
stratum corneum (SC). This lipid matrix is mainly composed
of cholesterol, free fatty acids (FFAs), and ceramides (Wertz,
2000; Feingold, 2009). The lipid composition determines the
lipid organization in the SC and is therefore a key factor in
determining the skin barrier function (Bouwstra and Ponec,
2006). We have previously investigated the SC lipid
organization of four of our in-house HSEs, namely, the
fibroblast-derived matrix model (FDM), Leiden epidermal
model (LEM), full-thickness collagen model (FTM), and full-
thickness outgrowth (FTO). The LEM is a skin equivalent with
only an epidermal compartment. The FDM is a model
wherein fibroblasts produce their own extracellular matrix,
whereas the FTM contains a dermal compartment that
consists of rat tail collagen populated with human fibroblasts.
In the FTO, a full-thickness explant of native human skin is
placed onto rat tail collagen and is allowed to expand and
develop an epidermis. The skin models mimic many aspects
of native human skin. However, they display some differ-
ences in their SC lipid organization. These differences may
have an important role in their decreased permeability barrier
compared with human SC (Thakoersing et al., 2012). As the
lipid organization is dictated by the lipid composition, we
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determined the SC lipid composition of each HSE in detail to
unravel the cause of their altered SC lipid organization. For
this purpose, we quantitatively assessed the SC lipid
composition of our in-house HSEs and native human SC
with high-performance thin-layer chromatography (HPTLC).
Nine ceramide subclasses have been identified in native
human SC using HPTLC (Ponec et al., 2003), whereas 12
ceramide subclasses have been identified using a recently
developed liquid chromatography/mass spectrometry (LC/
MS) method (Van Smeden et al., 2011). In this study, we used
LC/MS to determine whether all identified ceramide sub-
classes in native human SC are also present in the SC of our
HSEs. In addition, detailed information on the chain length
distribution and degree of saturation of each ceramide
subclass and FFAs is provided and compared with the SC of
native human skin. The expression pattern of several enzymes
involved in the FFA and ceramide synthesis was also
investigated to examine the biological cause of the altered
SC lipid properties observed in the HSEs. This study has led to
the identification of previously unreported targets that offer
previously unreported opportunities to optimize the SC lipid
properties of HSEs and mimic the barrier properties of native
human skin even more closely.
RESULTS
HPTLC analysis reveals that the HSEs have a reduced SC FFA
content compared with human skin
The SC lipids of the HSEs and human skin were extracted and
quantified with HPTLC to determine whether the HSEs show
differences in their lipid composition compared with human
skin. Figure 1a shows that SC of the HSEs contains cholesterol,
FFAs, and all ceramide subclasses, which are also observed in
human SC. In the LEM and FTM, an additional band of an
unidentified lipid, with an Rf value close to that of ceramide
EOH, can be observed. This unidentified lipid, which may
represent an unidentified ceramide, was occasionally also
observed in the FDM and FTO.
Figure 1b shows that human SC consists of approximately
equal amounts of cholesterol, FFAs, and ceramides. All HSEs,
however, show a different distribution of the SC barrier lipids
(Figure 1b). The relative FFA content in the HSEs, especially
in the FDM, LEM, and FTO, is much lower compared with
human SC. The SC lipid quantification also indicates that the
ceramide/cholesterol ratio (Supplemental Table S1 online) in
the LEM is increased and reduced in FTO compared with
human SC. This indicates that the relative ceramide and/or
cholesterol levels in the SC of the LEM and FTO differ from
the levels determined in human SC.
Most of the HSEs have an increased acylceramide content
compared with native human SC
In human SC, 12 ceramide subclasses are identified. Each
subclass is named according to its chemical structure (Motta
et al., 1993; Masukawa et al., 2008). In short, ceramides with
a sphingosine (S), phytosphingosine (P), 6-hydroxysphingo-
sine (H), or dihydrosphingosine (dS) backbone are linked via
an amide to a fatty acid chain, which can either be an
esterified o-hydroxy (EO), a-hydroxy (A), or non-hydroxy (N)
fatty acid. Figure 1c shows the ratio between the total
acylceramides (EO ceramides) and the other ceramide classes
(sum of all a-hydroxy þ non-hydroxy ceramides) in the HSEs
and native human skin. This figure clearly shows that the total
acylceramides level is much higher in the FDM, LEM, and FTO
compared with native human skin. Focusing on the individual
acylceramide levels, it is evident that the FDM, LEM, and FTO
have a higher content of ceramides EOS and EOH* compared
with human SC. The difference in EOP level between FDM,
LEM, FTO, and human SC is somewhat smaller compared with
the other acylceramides (Figure 1d). FTM has a small increase
in ceramide EOS and EOH* level compared with human SC,
while the EOP level is very similar (Figure 1d).
On the TLC plate, an unidentified lipid close to ceramide
EOH is observed in the LEM and FTM (Figure 1a). In the LC/MS
ceramide profiles of the HSEs, an unidentified group of lipids,
which have a molecular weight similar to acylceramides, is
also observed close to ceramide EOH (Figure 2b, indicated by
**). This suggests that the lipid band on the TLC plate most
likely represents an acylceramide class. For this reason, the
unidentified lipid was quantified together with ceramide EOH
(the two bands together are represented as EOH*).
The comparison of the a-hydroxy and non-hydroxy
ceramides also shows some differences in the distribution
of these ceramide subclasses between the HSEs and human
SC (Figure 1e). Ceramide NP is the most abundant ceramide
in human SC. Compared with human SC, the ceramide NP
content is reduced in the FTM and an even further reduction
is observed in the FDM, LEM, and FTO. In addition, the
ceramide AP content in the FTM is close to the ceramide
content in human SC, but reduced in the FDM, LEM, and
FTO. The relative content of ceramides NS þ NdS,
ceramides AS þ NH, and AH are similar in the HSEs and
human SC. Ceramides NS þ NdS and AS þ NH were
grouped together for quantification, because they comigrate
and therefore have a similar Rf value when using HPTLC.
All twelve ceramide subclasses detected in human SC are also
observed in the HSEs
LC/MS analysis of native human SC lipids shows the presence
of at least 12 ceramide subclasses, as reported previously
(Van Smeden et al., 2011) (Figure 2a). In addition, within one
ceramide subclass a large number of peaks are observed in
the multi-mass chromatogram. Each peak represents a
ceramide specie that has the same head group, but a different
total carbon chain length and therefore a different molecular
weight. In descending order, each specie has 14 mass units
less, which represents a reduction in one CH2 group
compared with the previous specie. All 12 ceramide
subclasses in human SC show a large variation in their total
carbon chain length distribution. In human SC, the acylcer-
amides have a total chain length varying from 63 to 78
carbon atoms. The a-hydroxy and non-hydroxy ceramide
subclasses have shorter total carbon chains, which range
from 34 to 50 and 34 to 56 carbon atoms, respectively. In
addition to the 12 identified ceramide subclasses, human SC
also shows the presence of some unidentified lipid classes.
These unidentified lipid classes also consist of several
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Figure 1. Stratum corneum barrier lipid content. Barrier lipids of human skin (HSC), fibroblast-derived matrix model (FDM), Leiden epidermal model (LEM),
full-thickness collagen model (FTM), and full-thickness outgrowth (FTO) were fractionated and quantified by high-performance thin-layer chromatography
(HPTLC) and photodensitometry. (a) Barrier lipid composition of human stratum corneum (SC) and human skin equivalents (HSEs). (b) Relative level of each SC
lipid class, (c) ratio of acylceramides (EO CERs) and non-acylceramides (non-EO CERs), (d) relative level of acylceramides, (e) relative level of a-hydroxy and
non-hydroxy ceramides. The data represent the sample meanþ SD of at least three analytical points. Ceramide nomenclature: A, a-hydroxy fatty acids;
CERs, ceramides; CHOL, cholesterol; dS, dihydrosphingosine; E, ester-linked fatty acids; FFA, free fatty acids; H, 6-hydroxy sphingosine; N, non-hydroxy fatty
acids; O, o-hydroxy fatty acids; P, phytosphingosine; S, sphingosine. *Unidentified lipid.
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species, indicated by the variation in total carbon chain
length. The molecular structure of these lipids remains to be
elucidated. The ceramide subclasses present in the FDM,
including the total chain length distribution of each subclass,
is provided in the multi-mass chromatogram in Figure 2b.
This figure shows that all 12 ceramide subclasses present in
native human SC are also detected in FDM. The other HSEs
show a very similar LC/MS profile as the FDM and also show
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Figure 2. Ceramide chain length distribution. Liquid chromatography/mass spectrometry (LC/MS) chromatogram of ceramide subclasses in (a) human
stratum corneum (SC) and (b) fibroblast-derived matrix model (FDM). The retention time, mass, and intensity of each peak are shown on the x-axis, y-axis, and
z-axis, respectively. The total carbon chain length variation of each ceramide subclass is provided in the inset. Ceramides with a low total carbon chain
length, which are present in lower quantities in human SC, are indicated by # in the chromatogram of FDM. Unidentified lipids only observed in the
chromatogram of FDM are specified with *. The unidentified lipid quantified together with ceramide EOH using high-performance thin-layer chromatography
(HPTLC) is indicated by **. Examples of ceramide species containing a monounsaturated fatty acid (MUFA) chain are shown in c. The masses of ceramide
species with a saturated or MUFA chain are shown in d. Ceramide nomenclature: A, a-hydroxy fatty acids; dS, dihydrosphingosine; E, ester-linked fatty acids;
H, 6-hydroxy sphingosine; N, non-hydroxy fatty acids; O, o-hydroxy fatty acids; P, phytosphingosine; S, sphingosine.
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the presence of all 12 ceramide subclasses (Supplementary
Figure S1 online). Each ceramide subclass in the HSEs shows
a wide variation in total chain length distribution, similar to
native human SC. In the HSEs, the acylceramides have a total
carbon chain that varies between 64 and 78 carbon atoms,
which is almost similar to the chain length distribution
observed for native human SC. The a-hydroxy and non-
hydroxy ceramide subclasses have a total carbon chain
between 32 and 50 and 34 and 56 carbon atoms,
respectively. When focusing in more detail on the LC/MS
profiles of the HSEs and native human SC, some differences
are observed. In the multi-mass chromatograms of the HSEs, a
weak lipid band is located just below the stronger peaks of
the ceramide species (Figure 2c), which is observed for all
ceramide subclasses. These additional weak lipid bands
always have a mass of two units less than that of stronger
band of the ceramide specie above them (Figure 2c and d).
This specific difference of two mass units suggests that the
lipid band represents a ceramide specie that contains a
monounsaturated fatty acyl chain. The multi-mass chromato-
grams of the HSEs also show low-molecular weight ceramide
species that are not detected in human SC. Furthermore,
some low-molecular weight ceramide species, which have
a mass below approximately 620 a.m.u., have a higher
intensity in the multi-mass chromatograms of the HSEs
compared with human skin. This is mainly observed for
species of ceramides AS and AH, which have a total chain
length of 34 carbon atoms (Figure 2b, indicated by #). The
HSEs show the presence of several unidentified lipids, of
which some are not present in the multi-mass chromatogram
of native human SC (Figure 2b indicated by *).
HSEs show an increased presence of monounsaturated FFAs
compared with native human SC
Figure 3 depicts the FFA chain length distribution and degree
of saturation in human SC and FDM. The other HSEs showed
a similar FFA composition as the FDM (Supplementary Figure
S1 online). Human SC shows a FFA chain length distribution
from C16:0 to C30:0. All HSEs contain FFAs with chain
lengths varying from C16:0 to C28:0. This indicates that the
HSEs are able to synthesize similar FFAs as native human
skin. However, the FFA LC/MS profiles of all HSEs
additionally show the presence of monounsaturated fatty
acids (MUFAs), which are hardly detected in human SC. The
MUFAs detected in the LC/MS profiles of the HSEs have a
chain length varying from C16:1 up to C34:1. All HSEs also
show a reduced level of FFAs with an odd carbon chain
length compared with human SC.
The HSEs show an altered expression of stearoyl-CoA
desaturase 1
To investigate the biological cause of the altered SC lipid
organization of the HSEs, the expression pattern of some
enzymes involved in the FFA and ceramide synthesis was
examined. Stearoyl-CoA desaturase (SCD) is the rate-limiting
enzyme that catalyzes the synthesis of MUFAs from saturated
fatty acids (Zhang et al., 1999; Ntambi et al., 2004). In native
human epidermis, SCD1 is only expressed in the basal layer
(Figure 4). In all HSEs, the expression of SCD is observed in
the basal layer, as well as in the differentiated layers of the
viable epidermis (Figure 4). This indicates that the expression
of SCD1 is altered in the HSEs compared with human skin.
The first step in ceramide synthesis is the coupling of
serine to palmitic acid by serine palmitoyltransferase (SPT)
(Gault et al., 2010). In human skin, SPT expression is
observed in the entire viable epidermis, showing both nucleic
and cytoplasmic staining. No difference in expression pattern
between human skin and the HSEs is observed (Figure 4).
Ceramide synthase 3 (CERS3) is one of the key enzymes
involved in de novo ceramide synthesis pathway. CERS3 has
a broad fatty acyl-coA preference and therefore n-acylates
both long- and very long–chain fatty acyl-CoAs to a sphingoid
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Figure 3. Fatty acid chain length distribution. Three-dimensional multi-mass liquid chromatography/mass spectrometry (LC/MS) chromatogram of free fatty
acids (FFAs) in (a) native human stratum corneum (SC) and (b) fibroblast-derived matrix model (FDM) are shown. The retention time is shown on the x-axis,
the mass (in a.m.u.) is provided on the y-axis, and the intensity of each peak is depicted on the z-axis. In human SC, the FFA chain length distribution varies
from C16:0 to C30:0. The FDM has a very similar FFA chain length distribution as human SC, but shows an increase in monounsaturated fatty acids (MUFAs)
with chain lengths varying from C16:1 to C34:1. In addition, the odd chain length FFAs show a lower intensity in the chromatogram of FDM compared
with human SC.
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base. Among the six CERS members (CERS 1-6), the mRNA
expression of CERS3 is found to be the highest in
differentiated keratinocytes in vitro (Mizutani et al., 2009).
In addition, a recent publication by Jennemann et al. (2012)
demonstrated that CERS3 is responsible for the synthesis of
very long–chain ceramides in the skin. In human skin and in
all HSEs, CERS3 is expressed in the entire viable epidermis
(Figure 4). It should be noted that the expression of SCD, SPT,
and CERS3 was weaker in the FTO samples compared with
the other HSEs.
DISCUSSION
In previous studies, we have investigated the SC lipid
organization of four in-house HSEs and native human skin.
These studies showed that our in-house HSEs have a mainly
hexagonal packing (Thakoersing et al., 2012), whereas
human SC has the dense orthorhombic packing (A schematic
representation of the SC lipid organization is depicted in
Supplementary Figure S2 online). The presence of a
hexagonal lipid organization has been correlated to a
decreased skin barrier function as monitored by transepider-
mal water loss compared with the orthorhombic packing
(Damien and Boncheva, 2010). We examined the SC lipid
composition of our HSEs in detail to verify the cause of their
altered SC lipid properties and to determine how the latter
can be optimized.
To our knowledge, it is previously unreported that the SC
of HSEs contain MUFAs, which may be a key factor for their
altered SC lipid organization. The increase in MUFA content
in the SC of HSEs coincides with the altered expression of
SCD1 in the viable epidermis of the HSEs compared with
human epidermis. It has been demonstrated that lipid
mixtures containing an equimolar ratio of cholesterol, FFAs,
and human ceramides predominantly form an orthorhombic
packing (Bouwstra et al., 2001). However, a reduction in
FFAs or the addition of MUFAs in such mixtures enhances the
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Figure 4. Expression pattern of enzymes involved in free fatty acid desaturation and de novo ceramide synthesis. Immunohistochemical staining showing
the expression pattern of stearoyl-CoA desaturase (SCD), serine palmitoyltransferase (SPT), and ceramide synthase 3 (CERS3) in human skin (HS), fibroblast-
derived matrix model (FDM), Leiden epidermal model (LEM), full-thickness collagen model (FTM), and full-thickness outgrowth (FTO). The negative
control represents sections on which only the secondary antibody was applied. The micrographs were taken at a  20 original magnification. Bar¼ 50mm.
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formation of a hexagonal lateral packing (Janssens et al.,
unpublished results). This indicates that the reduction in FFA
level and an increased presence of MUFAs contribute to the
formation of the hexagonal packing in our HSEs and thus may
be key factors in the observed increased benzocaine
penetration across the SC of HSEs compared with native
human skin. With respect to the lamellar phases, the HSEs
show the predominant presence of the long periodicity phase
(LPP) (Thakoersing et al., 2012), whereas in human SC both
the LPP and short PP are formed (Bouwstra et al., 1991). All
HSEs have an increased relative content of ceramides EOS
and EOH. As suggested in previous studies, these high
acylceramide levels may favor the formation of the LPP in
HSEs (De Jager et al., 2004), but does not make the HSEs
more permeable.
We show that all 12 ceramide subclasses observed in
native human SC are also present in the SC of all HSEs. This
indicates that the keratinocytes in our HSEs retain their ability
to synthesize all ceramide subclasses that are also present in
human SC. This observation represents a big step forward
in the characterization of the SC lipid properties of HSEs,
considering that until now a maximum of nine ceramide
subclasses were detected in HSEs, whereas in the commercial
HSEs even those nine ceramide classes were not always
present (Ponec et al., 1997, 2002, 2003).
Masukawa et al., (2009) quantified the ceramide composi-
tion in native human SC using LC/MS. The relative
prevalence of each ceramide class determined in this study
and the study of Masukawa et al. are very similar. In this
study, five synthetic ceramides are used for quantification
of the SC lipids in the HSEs and native human SC. The use
of several ceramide subclasses for quantification is very
important, as the charring intensities of the ceramide
subclasses differ considerably when equal amounts are
sprayed on TLC plates (Supplementary Figure S3 online).
The different composition of ceramide subclasses in the
FDM, LEM, and FTO compared with human skin is indicative
of an altered ceramide subclass synthesis in these HSEs. The
reason for this difference remains to be elucidated.
Our results demonstrate that the HSEs show a similar
expression of CERS3 as human skin. The LC/MS multi-mass
chromatograms indeed show that the HSEs are able to
synthesize ceramides with a large variety in total carbon
chain lengths, which are very similar to human skin. The
expression of SCD1 in the proliferating and differentiating
layers of the epidermis of the HSEs may result in an increased
activity of SCD1 in the differentiated epidermal layers and
thus an increased intracellular content of MUFAs in the
keratinocytes. Because of the increase in intracellular MUFA
content, the CERS enzymes, including CERS3, n-acylate both
MUFAs and saturated FFAs to the sphingoid bases. The
observation that an increase in MUFA content in the SC is
accompanied by the presence of ceramide species with a
monounsaturated fatty acyl chain suggests that fatty acids
present in the SC and the fatty acyl chains of ceramides have
a common source or synthetic pathway.
The results of this study indicate that the SC lipid
properties of the HSEs can be improved by increasing the
FFA content in the SC. The culture medium used to generate
the HSEs is supplemented with FFAs. Optimization of FFA
supplementation to the culture medium may lead to SC FFA
levels that more closely resemble the SC FFA level of native
human skin. At present, it is unclear why the HSEs show an
altered expression of SCD1 compared with human skin. It is
possible that the culture conditions or certain media
components, which are known to affect SCD expression or
activity, such as insulin, glucose, and fatty acids (Ntambi
et al., 2004; Mauvoisin and Mounier, 2011), lead to an
increased MUFA level in HSEs. However, it remains to be
established whether increased expression of SCD1 in the
suprabasal layers of the HSEs is truly associated with an
increased activity of SCD1 compared with native human
epidermis. If this appears to be true, the SC lipid properties
can additionally be improved by reducing SCD1 activity and
thereby the MUFA level in the SC of HSEs. SCD1 activity in
the HSEs may therefore be reduced by using, e.g., SCD
inhibitors (Ntambi et al., 2004; Liu, 2009) in the culture
medium. Studies performed by Miyazaki et al (Miyazaki
et al., 2005) have demonstrated that SCD-deficient mice
show skin permeability barrier defects, such as an insufficient
lipid deposition in the SC due to the presence of immature
lamellar bodies with a reduced lipid content, and a reduction
in acylceramide content. The reduction in SCD1 activity
should therefore be performed with care to prevent different
types of SC barrier defects in HSEs that may occur by a too
severe suppression of SCD1 activity. Optimization of the FFA
content in the SC of HSEs will be the subject of future studies.
MATERIALS AND METHODS
Cell culture
Native human mammary or abdomen skin was obtained from adults
undergoing surgery. Human skin left over from surgery was collected
after written informed consent of the skin donors and institutional
approval was obtained. The Declaration of Helsinki Principles were
followed when using human tissue. Normal human keratinocytes
(NHKs) and human dermal fibroblasts were isolated as described
before (Bouwstra et al., 2008). A detailed description of the required
media is provided as Supplemental Information online. NHKs used
to create HSEs with only an epidermal compartment were cultured
with the Dermalife K medium complete kit (Lifeline Cell Technol-
ogy, Walkersville, MD) supplemented with 1% penicillin/strepto-
mycin (Sigma, Zwijndrecht, The Netherlands) until they reached a
maximum confluency of 80%. First and second passage NHKs were
used to generate HSEs.
Dermal equivalents
Collagen-type I containing dermal equivalents. Collagen-type
I containing dermal equivalents were generated as described earlier
(Bouwstra et al., 2008). Details regarding the generation of the
dermal equivalents are provided as Supplemental Information
online.
Fully human dermal equivalents. The dermal matrices for the
FDMs were generated as described previously (El Ghalbzouri et al.,
2009). Details regarding the generation of the FDMs are provided as
Supplemental Information online.
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Generation of HSEs
HSEs generated on collagen dermal equivalents referred to
as FTM. One week after preparation of the collagen type I
containing dermal equivalents 0.5 106, NHKs were seeded on
top of each dermal equivalent. On the first 2 days, the HSEs were
kept submerged in a medium consisting of DMEM and Ham’s F12
(Invitrogen, Leek, The Netherlands) (3:1 v/v), 5% fetal bovine serum
(FBS), 1% penicillin/streptomycin, 0.5 mM hydrocortisone, 1 mM
isoproterenol and 0.5 mgml1 insulin. On the following 2 days, the
HSEs were kept submerged in a similar medium, except that the FBS
was reduced to 1% and 0.053 mM selenious acid (Johnson Matthey,
Maastricht, The Netherlands), 10mM L-serine (Sigma), 10 mM L-
carnitine (Sigma), 1 mM a-tocopherol acetate (Sigma), 25mM vitamin
C and a lipid mixture of 3.5 mM arachidonic acid (Sigma), 30 mM
linoleic acid (Sigma), 25mM palmitic acid (Sigma) were added to the
medium. Hereafter, the HSEs were lifted to the air/liquid interface
and were nourished with a medium in which the FBS was omitted
and the arachidonic acid concentration was increased to 7 mM. The
medium was refreshed twice a week. The HSEs were harvested
16 days after seeding of the NHKs onto the dermal equivalents.
HSEs generated on fully human dermal equivalents referred
to as FDM. Three weeks after seeding fibroblasts onto filter inserts
0.5 106, NHKs were seeded onto each dermal equivalent. The
HSEs were further cultured as described for the FTMs.
HSEs generated on inert filter, referred to as LEM. LEMs were
generated as described previously (El Ghalbzouri et al., 2008) with
slight modifications. 0.2 106 NHKs were seeded onto cell culture
inserts (Corning transwell cell culture inserts, membrane diameter
12mm, pore size 0.4mm, Corning Life Sciences, Amsterdam, The
Netherlands). The cells were kept submerged for 2–3 days in
Dermalife medium until confluency. On the following 2 days, the
HSEs were kept submerged in CnT medium (CellnTec, Bern,
Switzerland) supplemented according to the manufacturer’s protocol
and 1% penicillin/streptomycin solution, 1mM a-tocopherol acetate,
25mM vitamin C and a lipid mixture of 7mM arachidonic acid, 30mM
linoleic acid, and 25mM palmitic acid. Hereafter, the cells were
nourished with the same medium, but were grown at the air/liquid
interface. The LEMs were harvested 16 days after seeding the NHKs
onto the inserts.
Full-thickness cultures (FTO). Full-thickness (4mm) fat-free
punch biopsies obtained from abdomen or mammary skin were
gently pushed into freshly generated collagen type 1 containing
dermal equivalents. These HSEs were cultured similarly as described
for the FTMs and FDMs, except that they were directly cultured at the
air/liquid interface. The FTOs were grown for approximately 16 days.
Morphology and immunohistochemistry
Harvested HSEs were fixed in 4% (w/v) paraformaldehyde (Lom-
merse Pharma, Oss, The Netherlands), dehydrated, and subse-
quently embedded in paraffin. Five-micrometer sections were cut
and used for immunohistochemical staining of human SCD1 (100
dilution) (Sigma), SPT (400 dilution) (Cayman Chemicals,
Ann Arbor, MI) and CERS3 (10 dilution) (Atlas Antibodies,
Stockholm, Sweden). Immunohistochemical stainings of the samples
were performed with the R.T.U. Vectastain Elite ABC Reagent Kit
(Vector Laboratories, Burlingame, CA). Details of the staining
procedure are provided as Supplemental Information online.
SC isolation and lipid extraction
The SC of human abdomen or mammary skin was isolated as
described previously (Van Smeden et al., 2011). The SC lipids were
extracted according to the Bligh and Dyer procedure (Bligh and
Dyer, 1959) with a series of chloroform: methanol mixtures (1:2, 1:1,
and 2:1 v/v) for 1 hour each. The extracts were combined and treated
with 0.25 M KCl and water. The organic phase was collected and
evaporated under a stream of nitrogen at 40 1C. The obtained lipids
were redissolved in a suitable volume of chloroform: methanol
(2:1 v/v) and stored at 20 1C until use. To obtain enough lipids
for quantification, the lipid extracts of 2–4 HSEs from the same
experiment and donor were pooled. The SC lipid composition of the
full-thickness explant could not be determined, because there was
not enough material to extract.
HPTLC lipid quantification
The extracted SC lipids were quantified using HPTLC. The used
solvent system to separate the lipids is provided elsewhere
(Thakoersing et al., 2010). Co-chromatography of serial dilutions
of standards was used to identify and quantify each lipid class. The
standards consisted of cholesterol, palmitic acid, stearic acid,
arachidic acid, tricosanoic acid, behenic acid, lignoceric acid,
cerotic acid, and ceramides EOS, NS, NP, EOH, and AP. Ceramide
nomenclature according to terminology of Motta et al., (1993) and
Masukawa et al., (2008). The ceramides were provided by
Cosmoferm (The Netherlands). All other compounds were purchased
from Sigma. The lipid fractions were visualized and quantified as
described before (Rissmann et al., 2006). For quantification, SC lipid
samples of two donors were used of each HSE type and native
human skin.
LC/MS lipid analysis
The SC lipid species in the pooled lipid extracts of the HSEs
and native human skin were analyzed by LC/MS according to the
method described elsewhere (Van Smeden et al., 2011). Briefly: an
Alliance 2695 HPLC (Waters, Milford, MA) was coupled to a
TSQ Quantum MS (Thermo Finnigan, San Jose, CA) measuring in
APCI mode. The total lipid concentration of all samples was
around 1mgml1 and the injection volume was set to 10 ml
for the analysis of both ceramides and fatty acids. Ceramides were
separated using a PVA-Sil analytical column (5mm particle size,
100 2.1mm i.d. YMC, Kyoto, Japan) using a gradient mobile
phase from heptane to heptane/isopropyl alcohol/EtOH at a flow
rate of 0.8mlminute1. The scan range of the MS was set between
500 and 1200 a.m.u., measuring in positive ion mode. FFAs
were analyzed by introducing some adaptations to the setup
used for ceramide analysis, as will be described in detail elsewhere
(Van Smeden et al., in preparation): separation was achieved
using a LiChroCART Purospher STAR analytical column
(55 2mm i.d. Merck, Darmstadt, Germany) under a flow rate of
0.6mlminute1 using a gradient system from acetonitrile/H2O to
methanol/heptane. One percent of CHCl3 and 0.2% HAc were
added to both mobile phases as ionization enhancers. The ionization
mode and scan range was altered to negative mode and
200–600 a.m.u., respectively.
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